ATE94882T1 - Heparinbindende gehirnmitogene. - Google Patents

Heparinbindende gehirnmitogene.

Info

Publication number
ATE94882T1
ATE94882T1 AT89101187T AT89101187T ATE94882T1 AT E94882 T1 ATE94882 T1 AT E94882T1 AT 89101187 T AT89101187 T AT 89101187T AT 89101187 T AT89101187 T AT 89101187T AT E94882 T1 ATE94882 T1 AT E94882T1
Authority
AT
Austria
Prior art keywords
mitogens
heparin
brain
hbbms
promotion
Prior art date
Application number
AT89101187T
Other languages
English (en)
Inventor
Peter Bohlen
Peter Gautschi-Sova
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE94882T1 publication Critical patent/ATE94882T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Insulating Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Insulated Conductors (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT89101187T 1988-01-25 1989-01-24 Heparinbindende gehirnmitogene. ATE94882T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14783588A 1988-01-25 1988-01-25
EP89101187A EP0326075B1 (de) 1988-01-25 1989-01-24 Heparinbindende Gehirnmitogene

Publications (1)

Publication Number Publication Date
ATE94882T1 true ATE94882T1 (de) 1993-10-15

Family

ID=22523098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89101187T ATE94882T1 (de) 1988-01-25 1989-01-24 Heparinbindende gehirnmitogene.

Country Status (9)

Country Link
EP (1) EP0326075B1 (de)
JP (1) JPH01308300A (de)
AT (1) ATE94882T1 (de)
AU (1) AU624803B2 (de)
DE (1) DE68909254T2 (de)
DK (1) DK29889A (de)
ES (1) ES2058350T3 (de)
FI (1) FI890342A7 (de)
NO (1) NO175594C (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801426D0 (sv) * 1988-04-15 1988-04-15 Ulf Rothman Forfarande och medel for blodbehandling
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same
US6448381B1 (en) * 1990-01-08 2002-09-10 Barnes-Jewish Hospital DNA encoding heparin-binding growth factor
EP0452299B1 (de) * 1990-04-12 1997-06-18 EBEWE Arzneimittel Gesellschaft mbH Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
FR2665448A1 (fr) * 1990-08-01 1992-02-07 Paris Val De Marne Universite Procede d'obtention d'un peptide ayant une activite facteur de croissance, produit obtenu et son application comme medicament.
US5210026A (en) * 1990-08-20 1993-05-11 American Cyanamid Company Human mk gene and method of expression
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
EP0535337A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor
EP0535336A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Mk protein as cell growth inhibitor
FI980032A0 (fi) * 1998-01-09 1998-01-09 Heikki Matti Eemeli Rauvala Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl
US6364912B1 (en) 1999-09-17 2002-04-02 Depuy Orthopeaedics, Inc. Pleiotrophin-based compositions for enhancing connective tissue repair
US7888485B2 (en) 2003-03-26 2011-02-15 Georgetown University Anti-pleiotrophin antibodies and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597323B2 (en) * 1985-11-22 1990-05-31 Teijin Limited Angiogenic factor derived from blood vessel endothelial cells
EP0241136A3 (de) * 1986-03-07 1989-12-27 The President And Fellows Of Harvard College Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
FI890342L (fi) 1989-07-26
EP0326075A2 (de) 1989-08-02
EP0326075B1 (de) 1993-09-22
JPH01308300A (ja) 1989-12-12
ES2058350T3 (es) 1994-11-01
DK29889D0 (da) 1989-01-24
FI890342A0 (fi) 1989-01-24
FI890342A7 (fi) 1989-07-26
NO890295D0 (no) 1989-01-24
NO175594B (no) 1994-07-25
DK29889A (da) 1989-07-26
AU624803B2 (en) 1992-06-25
NO890295L (no) 1989-07-26
EP0326075A3 (en) 1989-10-18
DE68909254T2 (de) 1994-04-28
DE68909254D1 (de) 1993-10-28
NO175594C (no) 1994-11-02
AU2873789A (en) 1989-07-27

Similar Documents

Publication Publication Date Title
IT1214505B (it) Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
DE69727589D1 (de) Mutanten des KERATINOCYTEN-WACHSTUMSFAKTOR-2 (KGF-2 ODER FIBROBLASTENWACHSTUMSFAKTOR-12,FGF-12)
DK0429570T3 (da) Osteoinducerende præparater
ATE69376T1 (de) Haarwuchsmittel.
ATE94882T1 (de) Heparinbindende gehirnmitogene.
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
DE69021386D1 (de) Verfahren und zusammensetzungen zur heilung von geschwüren.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE69001839D1 (de) 1-hydroxyvitamin d2-epimer und dessen derivate.
DE3876052D1 (de) Medizinische verwendung.
RU97105008A (ru) Способ лечения диспластического сколиоза у детей
HUT50148A (en) Process for production of derivatives of antiflammation furanon and medical compositions containing them
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE3781250D1 (de) Verwendung vom "cartilage-inducing faktor b(cif-b)" zur herstellung eines arzneimittels gegen das wachstum von tumoren.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
EP0548123A4 (en) Anti-inflammatory factor, method of isolation, and use
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
EP0241136A3 (de) Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
ATE120799T1 (de) Mutein von hst-1 und seine herstellung.
DE68924545D1 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.
DE3784308D1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.